Tag: 2025 lineup
Top News
Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s...
D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.
- Our Sponsors Ad -